Peroxisome proliferator activated receptor γ agonists suppress TNFα-induced ICAM-1 expression by endothelial cells in a manner potentially dependent on inhibition of reactive oxygen species

Immunology Letters

Volumn 117, Issue 1, 2008, Pages 63-69

  Jung, Yuyeon ^a   Song, Seungjeong ^b   Choi, Chulhee ^b  

^a Ewha Womans University   (South Korea)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

Inflammation; Intercellular adhesion molecule 1; Peroxisome proliferator activated receptor ; Reactive oxygen species; Tumor necrosis factor

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; ACETYLCYSTEINE; CIGLITAZONE; DIPHENYLIODONIUM SALT; INTERCELLULAR ADHESION MOLECULE 1; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; ROSIGLITAZONE; TROGLITAZONE; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANTI-INFLAMMATORY AGENTS; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; NADPH OXIDASE; PPAR GAMMA; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS;

EID: 40649104327     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2007.12.002     Document Type: Article

References (37)

1. Kliewer S.A., Lehmann J.M., and Willson T.M. Orphan nuclear receptors: shifting endocrinology into reverse. Science 284 (1999) 757-760
2. Bailey S.T., and Ghosh S. 'PPAR'ting ways with inflammation. Nat Immunol 6 (2005) 966-967
3. 2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression. Diabetes 49 (2000) 346-355
4. Inoue H., Tanabe T., and Umesono K. Feedback control of cyclooxygenase-2 expression through PPARγ. J Biol Chem 275 (2000) 28028-28032
5. Oates J.C., Reilly C.M., Crosby M.B., and Gilkeson G.S. Peroxisome proliferator-activated receptor γ agonists: potential use for treating chronic inflammatory diseases. Arthritis Rheum 46 (2002) 598-605
6. Ricote M., Li A.C., Willson T.M., Kelly C.J., and Glass C.K. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391 (1998) 79-82
7. Woo C.H., Massett M.P., Shishido T., Itoh S., Ding B., McClain C., et al. ERK5 activation inhibits inflammatory responses via peroxisome proliferator-activated receptor δ (PPARδ) stimulation. J Biol Chem 281 (2006) 32164-32174
8. Eberhardt W., Akool el S., Rebhan J., Frank S., Beck K.F., Franzen R., et al. Inhibition of cytokine-induced matrix metalloproteinase 9 expression by peroxisome proliferator-activated receptor α agonists is indirect and due to a NO-mediated reduction of mRNA stability. J Biol Chem 277 (2002) 33518-33528
9. 2 inhibits multiple steps in the NF-κB signaling pathway. Proc Natl Acad Sci 97 (2000) 4844-4849
10. Cai H., and Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87 (2000) 840-844
11. Cai H., Li Z., Dikalov S., Holland S.M., Hwang J., Jo H., et al. NAD(P)H oxidase-derived hydrogen peroxide mediates endothelial nitric oxide production in response to angiotensin II. J Biol Chem 277 (2002) 48311-48317
12. Griendling K.K., Sorescu D., and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86 (2000) 494-501
13. Tardif J.C., Gregoire J., and L'Allier P.L. Prevention of restenosis with antioxidants: mechanisms and implications. Am J Cardiovasc Drugs 2 (2002) 323-334
14. Chen X.L., Tummala P.E., Olbrych M.T., Alexander R.W., and Medford R.M. Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ Res 83 (1998) 952-959
15. Schieffer B., Luchtefeld M., Braun S., Hilfiker A., Hilfiker-Kleiner D., and Drexler H. Role of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction. Circ Res 87 (2000) 1195-1201
16. Ushio-Fukai M., Tang Y., Fukai T., Dikalov S.I., Ma Y., Fujimoto M., et al. Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res 91 (2002) 1160-1167
17. Hallenbeck J.M. The many faces of tumor necrosis factor in stroke. Nat Med 8 (2002) 1363-1368
18. Chen X.-L., Zhang Q., Zhao R., Ding X., Tummala P.E., and Medford R.M. Rac1 and superoxide are required for the expression of cell adhesion molecules induced by tumor necrosis factor-α in endothelial cells. J Pharmacol Exp Ther 305 (2003) 573-580
19. 2, and iron are required for TNF-α-induced MCP-1 gene expression in endothelial cells: role of Rac1 and NADPH oxidase. Am J Physiol Heart Circ Physiol 286 (2004) H1001-H1007
20. Arai T., Kelly S.A., Brengman M.L., Takano M., Smith E.H., Goldschmidt-Clermont P.J., et al. Ambient but not incremental oxidant generation effects intercellular adhesion molecule 1 induction by tumour necrosis factor α in endothelium. Biochem J 331 Pt 3 (1998) 853-861
21. Szmitko P.E., Wang C.-H., Weisel R.D., de Almeida J.R., Anderson T.J., and Verma S. New markers of inflammation and endothelial cell activation: Part I. Circulation 108 (2003) 1917-1923
22. Sack M.N. Tumor necrosis factor-[alpha] in cardiovascular biology and the potential role for anti-tumor necrosis factor-α therapy in heart disease. Pharmacol Therap 94 (2002) 123-135
23. Law R.E., Goetze S., Xi X.P., Jackson S., Kawano Y., Demer L., et al. Expression and function of PPARgamma in rat and human vascular smooth muscle cells. Circulation 101 (2000) 1311-1318
24. Pasceri V., Wu H.D., Willerson J.T., and Yeh E.T. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-γ activators. Circulation 101 (2000) 235-238
25. Lee K.S., Kim S.R., Park S.J., Park H.S., Min K.H., Jin S.M., et al. Peroxisome proliferator activated receptor-γ modulates reactive oxygen species generation and activation of nuclear factor-κB and hypoxia-inducible factor 1α in allergic airway disease of mice. J Allergy Clin Immunol 118 (2006) 120-127
26. Park H.S., Chun J.N., Jung H.Y., Choi C., and Bae Y.S. Role of NADPH oxidase 4 in lipopolysaccharide-induced proinflammatory responses by human aortic endothelial cells. Cardiovasc Res 72 (2006) 447-455
27. Choi C., Kutsch O., Park J., Zhou T., Seol D.W., and Benveniste E.N. Tumor necrosis factor-related apoptosis-inducing ligand induces caspase-dependent interleukin-8 expression and apoptosis in human astroglioma cells. Mol Cell Biol 22 (2002) 724-736
28. Park J., Choi K., Jeong E., Kwon D., Benveniste E.N., and Choi C. Reactive oxygen species mediate chloroquine-induced expression of chemokines by human astroglial cells. Glia 47 (2004) 9-20
29. Pedruzzi E., Guichard C., Ollivier V., Driss F., Fay M., Prunet C., et al. NAD(P)H oxidase Nox-4 mediates 7-ketocholesterol-induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells. Mol Cell Biol 24 (2004) 10703-10717
30. Qureshi M.H., Cook-Mills J., Doherty D.E., and Garvy B.A. TNFα-dependent ICAM-1- and VCAM-1-mediated inflammatory responses are delayed in neonatal mice infected with Pneumocystis carinii. J Immunol 171 (2003) 4700-4707
31. Inoue I., Katayama S., Takahashi K., Negishi K., Miyazaki T., Sonoda M., et al. Troglitazone has a scavenging effect on reactive oxygen species. Biochem Biophys Res Commun 235 (1997) 113-116
32. 2 inhibits the β2 integrin-dependent oxidative burst: involvement of a mechanism distinct from peroxisome proliferator-activated receptor γ ligation. J Immunol 163 (1999) 6187-6192
33. Na H.-K., and Surh Y.-J. Peroxisome proliferator-activated receptor γ (PPARγ) ligands as bifunctional regulators of cell proliferation. Biochem Pharmacol 66 (2003) 1381-1391
34. Yoshizumi M., Fujita Y., Izawa Y., Suzaki Y., Kyaw M., Ali N., et al. Ebselen inhibits tumor necrosis factor-α-induced c-Jun N-terminal kinase activation and adhesion molecule expression in endothelial cells. Exp Cell Res 292 (2004) 1-10
35. Sugawara A., Uruno A., Kudo M., Ikeda Y., Sato K., Taniyama Y., et al. Transcription suppression of thromboxane receptor gene by peroxisome proliferator-activated receptor-γ via an interaction with Sp1 in vascular smooth muscle cells. J Biol Chem 277 (2002) 9676-9683
36. Wang L.H., Yang X.Y., Zhang X., Huang J., Hou J., Li J., et al. Transcriptional inactivation of STAT3 by PPARγ suppresses IL-6-responsive multiple myeloma cells. Immunity 20 (2004) 205-218
37. Choi Y.H., Kim H.I., Seong J.K., Yu D.Y., Cho H., Lee M.O., et al. B virus X protein modulates peroxisome proliferator-activated receptor γ through protein-protein interaction. FEBS Lett 557 (2004) 73-80